Flow Cytometry in Immuno-Oncology Research

Introduction

Immuno-oncology is the study of immune responses in the context of cancer, with a focus on harnessing and modulating the immune system to recognize and eliminate malignant cells. Immuno-oncology strategies—including immune checkpoint blockade, cancer vaccines, and adoptive cell therapies—rely on complex and dynamic interactions between immune cells and the tumor. These interactions are highly heterogeneous across patients, tumor types, and treatment stages, creating a critical need for advanced analytical technologies, such as flow cytometry, that can resolve immune responses at single-cell resolution.

Immune Checkpoint Molecule Detection

Immune checkpoints are regulatory pathways that modulate immune activation and maintain immune tolerance. In cancer, aberrant activation of checkpoint pathways such as PD-1/PD-L1 and CTLA-4 enables tumor cells to evade immune surveillance.

Flow cytometry allows quantitative, single-cell analysis of immune checkpoint molecules expressed on both tumor cells and immune cells. Using validated antibodies, markers such as PD-L1, CTLA-4, TIM-3, and other inhibitory receptors can be simultaneously assessed across defined cell subsets, providing detailed insight into immune regulatory networks within the tumor. Compared with bulk assays, flow cytometry offers superior resolution by distinguishing checkpoint expression patterns among specific immune populations, thereby supporting immunotherapy selection, biomarker discovery, and treatment stratification.

Key value

• Cell subset–specific quantification of immune checkpoint expression
• Supports immunotherapy target evaluation and patient stratification
• High analytical sensitivity driven by antibody quality

Immune Cell Functional Assessment

Immune cell function reflects the ability of immune cells to proliferate, secrete effector molecules, and induce tumor cell death, and is a key determinant of effective anti-tumor immunity.

Flow cytometry enables direct functional assessment of immune cells using antibody-based intracellular and surface staining. Cytokine production, such as IFN-γ and TNF-α, can be quantified at the single-cell level to evaluate T cell cytotoxic potential. In addition, cell proliferation and apoptosis provide important indicators of immune activation and treatment response. Ki-67 staining is commonly used to assess immune cell proliferation, while Annexin V/PI dual staining distinguishes early and late apoptotic stages, allowing comprehensive evaluation of immune and tumor cell responses to therapeutic interventions.

Key value

• Single-cell functional readouts beyond phenotypic analysis
• Quantitative evaluation of immune efficacy and treatment response
• Widely applied in immuno-oncology and antibody potency studies

Popular Targets